Dr Otis George Allen, MD | |
1215 Holiday Dr, Bloomington, IL 61704-2214 | |
(309) 827-3881 | |
(309) 661-0234 |
Full Name | Dr Otis George Allen |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 47 Years |
Location | 1215 Holiday Dr, Bloomington, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306847900 | NPI | - | NPPES |
036064804 | Medicaid | IL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 036064804 (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Joseph Medical Center | Bloomington, IL | Hospital |
Advocate Bromenn Medical Center | Normal, IL | Hospital |
Entity Name | Otis Allen Md Sc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457629842 PECOS PAC ID: 7416110085 Enrollment ID: O20120517000352 |
News Archive
A common observation in oncology is the phenomenon that a patient with a tumor receives a drug and responds very well, but after a few months the cancer comes back and is now resistant to previously administered chemotherapy. What happened? Many mechanisms contribute to explain this effect called "acquired resistance", but today the group Manel Esteller, Director of Epigenetics and Cancer Biology at the Bellvitge Biomedical Research Institute, ICREA researcher and Professor of Genetics at the University of Barcelona, describes in the official Journal of the National Cancer Research Center in the United States, The Journal of The National Cancer Institute, the existence of epigenetic differences that explain the lack of response of the tumor recurs.
A group of researchers led by Michael Diamond of Washington University in St. Louis have developed a vaccine that is effective in mice against Powassan virus, an emerging tick-borne virus that can cause life-threatening encephalitis in humans.
Laureate Biopharmaceutical Services, Inc. announced today that the U.S. Food and Drug Administration ("FDA") approved its application for an Electronic Submissions Gateway (ESG) to the Agency.
A multicenter research team has announced encouraging results for an experimental therapy using elements of the body's immune system to improve cure rates for children with neuroblastoma, a challenging cancer of the nervous system.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Otis George Allen, MD 53 Prenzler Dr, Bloomington, IL 61704-1299 Ph: (309) 287-8049 | Dr Otis George Allen, MD 1215 Holiday Dr, Bloomington, IL 61704-2214 Ph: (309) 827-3881 |
News Archive
A common observation in oncology is the phenomenon that a patient with a tumor receives a drug and responds very well, but after a few months the cancer comes back and is now resistant to previously administered chemotherapy. What happened? Many mechanisms contribute to explain this effect called "acquired resistance", but today the group Manel Esteller, Director of Epigenetics and Cancer Biology at the Bellvitge Biomedical Research Institute, ICREA researcher and Professor of Genetics at the University of Barcelona, describes in the official Journal of the National Cancer Research Center in the United States, The Journal of The National Cancer Institute, the existence of epigenetic differences that explain the lack of response of the tumor recurs.
A group of researchers led by Michael Diamond of Washington University in St. Louis have developed a vaccine that is effective in mice against Powassan virus, an emerging tick-borne virus that can cause life-threatening encephalitis in humans.
Laureate Biopharmaceutical Services, Inc. announced today that the U.S. Food and Drug Administration ("FDA") approved its application for an Electronic Submissions Gateway (ESG) to the Agency.
A multicenter research team has announced encouraging results for an experimental therapy using elements of the body's immune system to improve cure rates for children with neuroblastoma, a challenging cancer of the nervous system.
› Verified 1 days ago
Dr. Laura C Randolph, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2502 E Empire St, Suite C, Bloomington, IL 61704 Phone: 309-664-6222 Fax: 309-664-5006 | |
Dr. Paige C. Holt, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2502 E Empire St, Suite C, Bloomington, IL 61704 Phone: 309-664-4444 Fax: 309-664-5006 | |
Dr. Chad Tattini, Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2502 E Empire St, Suite C, Bloomington, IL 61704 Phone: 309-664-1007 Fax: 309-664-5006 |